This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of Kansas, Florida Memorial University, Tufts University. Active years: 2014.
Location History:
- Lenexa, KS (US) (2014)
- Wallenstein, CA (2014)
Company Filing History:
2 out of 571 
1 out of 1 
1 out of 653 
Years Active: 2014
Title: The Innovative Mind of Todd Holyoak
Introduction
Todd Holyoak, an accomplished inventor based in Lenexa, Kansas, has made significant contributions to the field of biochemistry with his innovative inventions. Holding a total of two patents, he has focused on developing novel polypeptide agents and inhibitors that hold promise for treatment methods in various medical conditions.
Latest Patents
One of Holyoak's most recent patents focuses on IGA1 protease polypeptide agents and their uses. These polypeptide agents are designed to be useful in the treatment of IgA1 deposition diseases. The patent also includes methods for screening inhibitors of IgA1 proteases, providing important tools for medical research and therapeutic development.
His second patent describes an inhibitor scaffold specifically aimed at the inhibition of the enzyme phosphoenolpyruvate carboxykinase (PEPCK). This innovative approach allows for the identification of molecules capable of interacting with the PEPCK binding site, emphasizing various structural requirements for potential inhibitors that can combat diseases related to metabolic dysfunction.
Career Highlights
Holyoak's career has been marked by his association with prestigious institutions, including the University of Kansas and Tufts Medical Center, Inc. His work in these organizations has facilitated a rich environment for research and development, leading to the breakthroughs evidenced by his patents.
Collaborations
Throughout his career, Holyoak has collaborated with talented individuals, notably Jiazhou Qiu and Andrew G. Plaut. These partnerships have not only enriched his research but have also contributed to the broader scientific community's understanding of biochemistry and health.
Conclusion
Todd Holyoak continues to be a driving force in innovation, with his inventions paving the way for future research in the treatment of complex diseases. His dedication to advancing biochemistry through patentable inventions highlights the importance of collaboration and creativity in scientific exploration.